Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2026-03-03 @ 5:04 PM
Study NCT ID:
NCT02374333
Status:
COMPLETED
Last Update Posted:
2021-09-23
First Post:
2015-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy
Sponsor:
University of Pennsylvania
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-02
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-23
First Submit QC Date:
None
Study First Post Date:
2015-02-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-22
Last Update Post Date:
2021-09-23
Last Update Post Date Type:
ACTUAL